BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36694958)

  • 1. The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma.
    Hirokawa S; Araki K; Yamashita T; Uno K; Tomifuji M; Shimada H; Shiotani A
    Acta Otolaryngol; 2023 Jan; 143(1):85-90. PubMed ID: 36694958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study.
    Takashi S; Satoshi Y; Akihiko O; Naoya Y; Yusuke T; Kentaro M; Yu O; Yasuaki N; Koichi Y; Takashi F; Ryo O; Isamu H; Chikara K; Kosuke N; Yasuhiro T; Kazuhiko Y; Hideaki S
    Esophagus; 2021 Jan; 18(1):65-71. PubMed ID: 32715348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum p53 antibodies detection in oral squamous cell carcinoma, oral potentially malignant disorders and healthy individuals: A multicentre study.
    Khan AS; Ahmad S; Ullah Z; Haq M; Farooq MU; Khan M
    J Pak Med Assoc; 2021 Oct; 71(10):2364-2368. PubMed ID: 34974572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating anti-p53 antibodies in esophageal cancer patients.
    Hagiwara N; Onda M; Miyashita M; Sasajima K
    J Nippon Med Sch; 2000 Apr; 67(2):110-7. PubMed ID: 10754600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma.
    Kochi R; Yajima S; Nanami T; Suzuki T; Oshima Y; Tokura N; Takatsuka J; Funahashi K; Tochigi N; Shimada H
    Clin J Gastroenterol; 2018 Aug; 11(4):278-281. PubMed ID: 29497977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
    Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the p53-p16/RB pathway control mechanism in early-stage carcinogenesis in head and neck squamous cell carcinoma.
    Mori T
    Pathol Int; 2022 Dec; 72(12):577-588. PubMed ID: 36218243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of superficial pharyngeal squamous cell carcinoma in Japan.
    Rikitake R; Ando M; Saito Y; Yoshimoto S; Yamasoba T; Higashi T
    Int J Clin Oncol; 2017 Oct; 22(5):826-833. PubMed ID: 28501947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
    Shimada H; Ochiai T; Nomura F;
    Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma.
    Shiratori F; Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Funahashi K; Shimada H
    Esophagus; 2019 Jul; 16(3):246-251. PubMed ID: 30778774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
    Lechpammer M; Lukac J; Lechpammer S; Kovacević D; Loda M; Kusić Z
    Int J Colorectal Dis; 2004 Mar; 19(2):114-20. PubMed ID: 14634775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
    Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma.
    Chow V; Yuen AP; Lam KY; Ho WK; Wei WI
    Head Neck; 2001 Apr; 23(4):286-91. PubMed ID: 11400229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
    PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of p16 surrogate biomarker as adjunct diagnosis of oral and oropharyngeal malignancy in a resource-constrained country.
    Adham M; Aldino N; Zahra S; Rachmadi L; Bardosono S
    Acta Otolaryngol; 2021 Jan; 141(1):106-110. PubMed ID: 33085553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma.
    Takahashi K; Miyashita M; Nomura T; Makino H; Futami R; Kashiwabara M; Katsuta M; Tajiri T
    Dis Esophagus; 2007; 20(2):117-22. PubMed ID: 17439594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma.
    Ito M; Hiwasa T; Yajima S; Suzuki T; Oshima Y; Nanami T; Sumazaki M; Shiratori F; Li SY; Iwadate Y; Sugimoto K; Mori M; Kuwabara S; Takizawa H; Shimada H
    Esophagus; 2022 Oct; 19(4):617-625. PubMed ID: 35780443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.